News and Events - Catalent
Oct 29, 2024 · Catalent announced today that it has entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in Somerset, NJ to Ardena, a …
Catalent's Open Letter to Customers Regarding Novo Holdings
Oct 21, 2024 · Alessandro Maselli to Remain President and CEO of Catalent Post-Close. October 21, 2024 – SOMERSET, N.J. – Catalent, Inc. (NYSE: CTLT), the leader in enabling the …
Catalent Signs Agreement to Sell Somerset, NJ Oral Solids Facility
Oct 14, 2024 – Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, announced today that it has entered into a …
Catalent, Inc. - Novo Holdings to Acquire Catalent
Feb 5, 2024 · Of Catalent’s more than 50 global sites, Novo Holdings intends to sell three Catalent fill-finish sites and related assets acquired in the merger to Novo Nordisk (CPH: …
Catalent to Acquire Metrics Contract Services for $475 Million
Aug 9, 2022 · Upon completion, the acquisition will strengthen Catalent’s capabilities in integrated oral solid formulation development, manufacturing, and packaging to help customers simplify …
Moderna and Catalent Partner on COVID-19 Vaccine Candidate
Jun 25, 2020 · Moderna and Catalent today announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine candidate …
Catalent Announces New Operating Structure
Jul 5, 2022 · Catalent's new organizational structure includes a shift from four reporting segments to two, each representing roughly half of the total company revenue.
Sarepta and Catalent Expand Strategic Manufacturing Partnership
Jan 5, 2023 · Catalent & Sarepta partner to manufacture delandistrogene moxeparvovec, an advanced candidate to treat Duchenne muscular dystrophy.
Catalent Acquires Princeton Cell Therapy Facility from Erytech
Apr 25, 2022 · Catalent's agreement with Erytech Pharma acquires the state-of-the-art cell therapy manufacturing facility in Princeton for $44.5 million.
Catalent Opens Therapy Manufacturing Facilities in Belgium
SOMERSET, N.J. – December 8, 2022 — Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better …